Navigation Links
Genomatix takes a lead in Next Generation Sequencing
Date:1/31/2008

Genomatix is a company with a renowned track record in the analysis of genomic data generated by high throughput technologies. Genomatix algorithms include optimized fast mapping strategies and Genomatix already provides the most complete genome annotation in terms of transcriptome and promoters available in its ElDorado database surpassing alternative databases in this specific content by a factor of 2 to 4.

Pilot studies in collaboration with customers, successfully analyzing Next Generation Sequencing data (from 454 and Solexa) have firmly established that ElDorado brings a dramatic advantage to NGS data processing and interpretation, providing additional information about the transcriptome and its regulation. Result data can be visualized by ElDorado in the full genomic annotation context and a variety of correlation studies and further downstream analyses are possible using other established Genomatix services.

Genomatix announces today that services for NGS studies are available within our consulting model, effective immediately, including Digital Gene Expression (DGE) Studies as well as Chip Sequencing (ChiPSeq) Assays. Inquiries are welcome.


'/>"/>

Contact: Peter Grant
grant@genomatix-software.com
877-436-6628
Genomatix Software GmbH
Source:Eurekalert

Page: 1

Related medicine news :

1. NIH/NCI renews and extends nationwide license for Genomatix software and databases
2. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
3. Free will takes flight: how our brains respond to an approaching menace
4. New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market
5. Sun Safety Outreach to Families Takes Flight at the Plano Hot Air Balloon Festival
6. Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts
7. Small Town Doctor Takes on Giants in Consumer Healthcare
8. Help is Available for Smokers Who Want to Quit as Minnesotas Smoke-Free Law Takes Effect Oct. 1
9. Growing Healthy with School Gardens Takes Root in Los Angeles Saturday
10. Randy Jackson Takes Aim at Diabetes
11. New Hampshire: 1st in the Nation Primary State Takes a Stand on E-Prescribing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the release of two biometric time and attendance tracking products: the new NCheck ... software. NCheck Cloud Bio Attendance uses biometric face recognition to enable users to ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... ... A minimally invasive porcelain veneer is increasing in popularity ... Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive dentistry, ... and technicians that create these veneers. , According to National Board for ...
(Date:3/28/2017)... ... ... Public relations pros work hard to earn placements and build a ... results are clear, much of PR is hard to quantify. Goal-setting and measurement are ... firms should always take an all-inclusive approach that takes both traditional and non-traditional factors ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... This morning,s research on ... The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals Inc. ... Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ). ... which is governed by the same governing framework ... industry are wholesalers, retailers, pharmacies, and benefit managers. Learn ...
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that the European Medicines Agency (EMA) has notified ... 30 mcg) Marketing Authorisation Application (MAA) has passed ... MAA is underway. The MAA for ARX-04 (known ...
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
Breaking Medicine Technology: